HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Caulfield, M. T. Articles by O’Brien, K. D. Search for Related Content PubMed Articles by Caulfield, M. T. Articles by O’Brien, K. D. Social Bookmarking                What's this?

Cardiovascular Safety of Oral Antidiabetic Agents: The Insulin Secretagogues

In Brief

This article reviews and dispels concerns about the potential cardiotoxicity of insulin and oral diabetes drugs, specifically the insulin secretagogues, in patients with type 2 diabetes. The authors focus on insulin and the sulfonylurea drugs but also briefly discuss meglitinide analogs.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. L. Weintraub Impaired Hypoxic Coronary Vasodilation and ATP-Sensitive Potassium Channel Function: A Manifestation of Diabetic Microangiopathy in Humans? Circ. Res., February 7, 2003; 92(2): 127 - 129. [Full Text] [PDF]